For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of RAPT Therapeutics Inc (NASDAQ: RAPT) closed at $1.12 in the last session, up 3.70% from day before closing price of $1.08. In other words, the price has increased by $3.70 from its previous closing price. On the day, 0.68 million shares were traded. RAPT stock price reached its highest trading level at $1.2 during the session, while it also had its lowest trading level at $1.11.
Ratios:
We take a closer look at RAPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.90 and its Current Ratio is at 9.90. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on November 13, 2024, Downgraded its rating to Hold and sets its target price to $2 from $7 previously.
On November 11, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $8 to $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 39153296 and an Enterprise Value of -53631756.
Stock Price History:
The Beta on a monthly basis for RAPT is 0.08, which has changed by -0.92426366 over the last 52 weeks, in comparison to a change of 0.31053436 over the same period for the S&P500. Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -38.73%, while the 200-Day Moving Average is calculated to be -76.91%.
Shares Statistics:
According to the various share statistics, RAPT traded on average about 516.27K shares per day over the past 3-months and 1718040 shares per day over the past 10 days. A total of 34.40M shares are outstanding, with a floating share count of 30.56M. Insiders hold about 12.58% of the company’s shares, while institutions hold 75.02% stake in the company. Shares short for RAPT as of 1730332800 were 2668533 with a Short Ratio of 5.17, compared to 1727654400 on 3139136. Therefore, it implies a Short% of Shares Outstanding of 2668533 and a Short% of Float of 10.27.
